{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:09:00Z","timestamp":1790341740701,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gene.2026.150248","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:26:10Z","timestamp":1780356370000},"page":"150248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Apabetalone mediates HIV-1 transcriptional activation and clearance of latently infected cells via LncRNA OSER1-AS1"],"prefix":"10.1016","volume":"1006","author":[{"given":"Bo","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1340-2553","authenticated-orcid":false,"given":"Liying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","article-title":"Optimizing treatment for adults with HIV\/AIDS in China: successes over two decades and remaining challenges","volume":"17","author":"Cao","year":"2020","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"4","key":"10.1016\/j.gene.2026.150248_b0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.chom.2020.03.022","article-title":"HIV\/AIDS research for the future","volume":"27","author":"Gallo","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.gene.2026.150248_b0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2020.09.004","article-title":"Timeline: HIV","volume":"183","author":"Agarwal-Jans","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/cells13010064","article-title":"Advancements in cell-based therapies for HIV cure","volume":"13","author":"Matsui","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virs.2022.01.017","article-title":"Updates on CRISPR-based gene editing in HIV-1\/AIDS therapy","volume":"37","author":"Zhang","year":"2022","journal-title":"Virol. Sin."},{"issue":"9","key":"10.1016\/j.gene.2026.150248_b0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40265-020-01322-y","article-title":"Novel Approaches Towards a Functional Cure of HIV\/AIDS","volume":"80","author":"Bailon","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/02648725.2018.1471641","article-title":"Combating the HIV reservoirs","volume":"34","author":"van Marle","year":"2018","journal-title":"Biotechnol. Genet. Eng. Rev."},{"issue":"8","key":"10.1016\/j.gene.2026.150248_b0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/v12080868","article-title":"Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome","volume":"12","author":"Hokello","year":"2020","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.gene.2026.150248_b0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/1873-3468.14033","article-title":"AP-1 and NF-\u03baB synergize to transcriptionally activate latent HIV upon T-cell receptor activation","volume":"595","author":"Hokello","year":"2021","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0050","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1038\/s41467-024-49622-1","article-title":"RPLP1 restricts HIV-1 transcription by disrupting C\/EBP\u03b2 binding to the LTR","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12974-018-1129-1","article-title":"Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation","volume":"15","author":"Khan","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.gene.2026.150248_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119451","article-title":"Could gene therapy cure HIV?","volume":"277","author":"Sheykhhasan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.gene.2026.150248_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118427","article-title":"A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-\u03baB pathway","volume":"267","author":"Lu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.gene.2026.150248_b0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-981-13-0484-2_12","article-title":"Clinical interventions in HIV cure research","volume":"1075","author":"Rasmussen","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"10","key":"10.1016\/j.gene.2026.150248_b0075","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/v13102037","article-title":"The novel PKC activator 10-methyl-Aplog-1 combined with JQ1 induced strong and synergistic HIV reactivation with tolerable global T cell activation","volume":"13","author":"Washizaki","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.gene.2026.150248_b0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3389\/fmicb.2017.01035","article-title":"A novel bromodomain inhibitor reverses HIV-1 latency through specific binding with BRD4 to promote Tat and P-TEFb association","volume":"8","author":"Huang","year":"2017","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.gene.2026.150248_b0085","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/v13061026","article-title":"Are BET inhibitors yet promising latency-reversing agents for HIV-1 reactivation in AIDS therapy?","volume":"13","author":"Salahong","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.gene.2026.150248_b0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/acsptsci.3c00219","article-title":"Apabetalone (RVX-208): a potential epigenetic therapy for the treatment of cardiovascular, renal, neurological, viral, and cancer disorders","volume":"7","author":"Dhulkifle","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"49","key":"10.1016\/j.gene.2026.150248_b0095","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1073\/pnas.1310658110","article-title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","volume":"110","author":"Picaud","year":"2013","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41401-018-0027-5","article-title":"The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation","volume":"40","author":"Zhang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13578-024-01326-1","article-title":"Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma","volume":"14","author":"Zou","year":"2024","journal-title":"Cell Biosci."},{"issue":"7794","key":"10.1016\/j.gene.2026.150248_b0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","article-title":"Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer","volume":"578","author":"Faivre","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gene.2026.150248_b0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.65.8.11","article-title":"BET bromodomain inhibition potentiates ocular melanoma therapy by inducing cell cycle arrest","volume":"65","author":"Chen","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0120","doi-asserted-by":"crossref","first-page":"16646","DOI":"10.1038\/s41598-017-16816-1","article-title":"BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.gene.2026.150248_b0125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/cc.23309","article-title":"BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism","volume":"12","author":"Boehm","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.gene.2026.150248_b0130","doi-asserted-by":"crossref","first-page":"24100","DOI":"10.1038\/srep24100","article-title":"The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb","volume":"6","author":"Lu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150248_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ddtec.2016.06.004","article-title":"Clinical trials for BET inhibitors run ahead of the science","volume":"19","author":"Andrieu","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.gene.2026.150248_b0140","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-7-266","article-title":"Cell line-dependent variability in HIV activation employing DNMT inhibitors","volume":"7","author":"Fernandez","year":"2010","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.gene.2026.150248_b0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/21541264.2018.1523668","article-title":"CDK9: a signaling hub for transcriptional control","volume":"10","author":"Bacon","year":"2019","journal-title":"Transcription"},{"issue":"10","key":"10.1016\/j.gene.2026.150248_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02056-17","article-title":"A new quinoline BRD4 inhibitor targets a distinct latent HIV-1 reservoir for reactivation from other \u201cshock\u201d drugs","volume":"92","author":"Abner","year":"2018","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0155","doi-asserted-by":"crossref","first-page":"e00596","DOI":"10.1128\/mBio.00596-12","article-title":"NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression","volume":"4","author":"Zhang","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.gene.2026.150248_b0160","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1038\/srep08639","article-title":"The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins","volume":"5","author":"Imam","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150248_b0165","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.omtn.2020.04.011","article-title":"A Novel lncRNA, AK130181, contributes to HIV-1 latency by regulating viral promoter-driven gene expression in primary CD4+ T cells","volume":"20","author":"Li","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.gene.2026.150248_b0170","first-page":"1365","article-title":"LncRNA OSER1-AS1 interacts with miR-612\/FOXM1 axis to modulate gefitinib resistance of lung adenocarcinoma","volume":"13","author":"Shi","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0175","doi-asserted-by":"crossref","first-page":"12285","DOI":"10.1038\/s41598-019-48777-y","article-title":"BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation","volume":"9","author":"Khan","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.gene.2026.150248_b0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40164-024-00484-9","article-title":"The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma","volume":"13","author":"Yan","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"794","key":"10.1016\/j.gene.2026.150248_b0185","article-title":"ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity-independent manner","volume":"16","author":"Morante","year":"2023","journal-title":"Sci. Signal."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:22:44Z","timestamp":1782404564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926002581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S0378111926002581"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150248","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apabetalone mediates HIV-1 transcriptional activation and clearance of latently infected cells via LncRNA OSER1-AS1","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150248"}}